Skip to main content
. 2017 Nov 10;2017(11):CD011767. doi: 10.1002/14651858.CD011767.pub2

Johansen 2016.

Study characteristics
Patient sampling Study design: prospective cohort study.
 Participants: pregnant women selected at high risk of fetal aneuploidy presenting for invasive testing.
 Inclusion criteria: singleton pregnancies.
 Exclusion criteria: multifetal pregnancies.
Patient characteristics and setting Number enrolled: 375 pregnant women (184 for the validation set).
 Number available for 2 x 2 table: 173 pregnant women (subgroup of 94%).
 Setting: Danish public health setting.
 Recruitment period: not reported.
 Ethnicity: not reported.
 Median gestational age (range): 13.4 (10.6 to 31) weeks.
 Maternal age: not reported.
 Relevant tests carried out prior to index test: ultrasonography (nuchal translucency measurement) or biochemical screening or both.
 Language of the study: English.
Index tests gNIPT by MPSS on Ion Proton™ sequencer in 5‐plex.
Fetal fraction DNA: amount measured but not reported.
 Blood samples for gNIPT were collected just before reference standard.
 Cutpoint: positive if Z score ≥ 4 and WISECONDOR ≥ 1% (unclassified if Z score between 3 and 4).
 In‐house test.
Target condition and reference standard(s) Target conditions: T21, T18 and T13.
 Reference standard: fetal karyotype of chorionic villi or amniotic fluid.
Flow and timing Blood samples for gNIPT were obtained just prior the invasive procedure (reference standard).
 gNIPT was a second‐tier test.
191/375 not selected, samples for the validation set were excluded.
 11/184 samples failed during sequencing process for low fetal fraction DNA (no gNIPT result).
2/173 samples were resequenced because gNIPT results were in the inconclusive zone and 2 results were obtained.
Comparative  
Aim to study To introduce gNIPT for fetal autosomal trisomies and gender in a Danish public health setting, using semi‐conductor sequencing and published open source scripts for analysis.
Funding source or sponsor of the study No funding source was reported.
Informations about the authors contacted No need for further contact.
Notes  
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? No    
    High Low
DOMAIN 2: Index Test MPSS
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all analysed patients receive the reference standard? Yes    
Were all patients included in the analysis? No    
    High